中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
13期
140-141
,共2页
偏头痛%通心络胶囊%盐酸氟桂嗪
偏頭痛%通心絡膠囊%鹽痠氟桂嗪
편두통%통심락효낭%염산불계진
Migraine%Tongxinluo capsule%Flunarizine
目的：研究通心络胶囊与盐酸氟桂嗪治疗偏头痛的临床治疗效果。方法整群选取2012年9月-2014年5月间在该院接受治疗的偏头痛患者288例，将其随机分为观察组和对照组，两组各有患者144例。观察组患者服用通心络胶囊进行治疗；对照组患者服用盐酸氟桂嗪胶囊。治疗结束后对比两组治疗效果。结果观察组偏头痛患者治疗前评分为(17.61±1.32)，治疗后评分(6.14±2.11)；对照组偏头痛患者治疗前评分为(16.94±1.59)，治疗后评分为(10.51±3.12)，两组偏头痛患者的数据差异有统计学意义(P<0.05)。观察组144例偏头痛患者经过治疗后，治疗后效果为控制的患者有49例(34.03%)，治疗总有效率为91.67%；对照组144例偏头痛患者经过治疗后，治疗后效果为控制的患者有26例(18.06%)，治疗总有效率为88.19%。两组偏头痛患者在接受治疗后治疗效果差异无统计学意义(P>0.05)，但观察组控制率明显优于对照组，且差异有统计学意义(P<0.05)。结论通心络胶囊与盐酸氟桂嗪对偏头痛患者均有着较好的治疗效果，但通心络胶囊综合方面优势明显，患者控显率较高，治疗后评分优于盐酸氟桂嗪。
目的：研究通心絡膠囊與鹽痠氟桂嗪治療偏頭痛的臨床治療效果。方法整群選取2012年9月-2014年5月間在該院接受治療的偏頭痛患者288例，將其隨機分為觀察組和對照組，兩組各有患者144例。觀察組患者服用通心絡膠囊進行治療；對照組患者服用鹽痠氟桂嗪膠囊。治療結束後對比兩組治療效果。結果觀察組偏頭痛患者治療前評分為(17.61±1.32)，治療後評分(6.14±2.11)；對照組偏頭痛患者治療前評分為(16.94±1.59)，治療後評分為(10.51±3.12)，兩組偏頭痛患者的數據差異有統計學意義(P<0.05)。觀察組144例偏頭痛患者經過治療後，治療後效果為控製的患者有49例(34.03%)，治療總有效率為91.67%；對照組144例偏頭痛患者經過治療後，治療後效果為控製的患者有26例(18.06%)，治療總有效率為88.19%。兩組偏頭痛患者在接受治療後治療效果差異無統計學意義(P>0.05)，但觀察組控製率明顯優于對照組，且差異有統計學意義(P<0.05)。結論通心絡膠囊與鹽痠氟桂嗪對偏頭痛患者均有著較好的治療效果，但通心絡膠囊綜閤方麵優勢明顯，患者控顯率較高，治療後評分優于鹽痠氟桂嗪。
목적：연구통심락효낭여염산불계진치료편두통적림상치료효과。방법정군선취2012년9월-2014년5월간재해원접수치료적편두통환자288례，장기수궤분위관찰조화대조조，량조각유환자144례。관찰조환자복용통심락효낭진행치료；대조조환자복용염산불계진효낭。치료결속후대비량조치료효과。결과관찰조편두통환자치료전평분위(17.61±1.32)，치료후평분(6.14±2.11)；대조조편두통환자치료전평분위(16.94±1.59)，치료후평분위(10.51±3.12)，량조편두통환자적수거차이유통계학의의(P<0.05)。관찰조144례편두통환자경과치료후，치료후효과위공제적환자유49례(34.03%)，치료총유효솔위91.67%；대조조144례편두통환자경과치료후，치료후효과위공제적환자유26례(18.06%)，치료총유효솔위88.19%。량조편두통환자재접수치료후치료효과차이무통계학의의(P>0.05)，단관찰조공제솔명현우우대조조，차차이유통계학의의(P<0.05)。결론통심락효낭여염산불계진대편두통환자균유착교호적치료효과，단통심락효낭종합방면우세명현，환자공현솔교고，치료후평분우우염산불계진。
Objective Clinical study on the therapeutic effect of Tongxinluo capsule and flunarizine in treatment of migraine. Methods Select between September 2012-May 2014 in our hospital treated 288 cases of migraine patients were randomly divided into two groups and the control group, 144 cases of patients in each group. Observed in patients taking Tongxinluo treatment;con-trol group of patients taking fluoride flunarizine hydrochloride capsules. Comparative effects of treatment, after treatment. Results Observation group migraine patients before treatment score for (17.61±1.32), (6.14±2.11) score after treatment; migraine patients in the control group before the score was (16.94±1.59), after treatment score was (10.51±3.12), two groups of migraine patients have significant data difference (P<0.05). Observation group 144 cases of migraine patients after treatment, after treatment for a patient-controlled 49 cases (34.03%), total effective rate was 91.67%;control group, 144 cases of migraine patients after treatment, after treatment for control there are 26 cases of patients (18.06%), total effective rate was 88.19%. Two groups of patients with mi-graine was no significant difference (P>0.05) after receiving therapeutic effect, but the size of the observation group control rate and effective rate than the control group, and the difference was significant (P<0.05). Conclusion Tongxinluo and flunarizine for migraine patients have a better therapeutic effect, but Tongxinluo comprehensive obvious advantages, significantly higher rate con-trol in patients after treatment scores than flunarizine.
